Thinking inside the box

New England Journal of Medicine

Volumn 363, Issue 6, 2010, Pages 574-579

  Jessel, Peter ^a   Safdar, Nasia ^c   McCune, W Joseph ^a   Saint, Sanjay ^a,b   Kaul, Daniel R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; AMPICILLIN; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEFTRIAXONE; CORTICOSTEROID; DILTIAZEM; FOLIC ACID; GABAPENTIN; HEPARIN; HYDROCHLOROTHIAZIDE; INFLIXIMAB; LEVOFLOXACIN; METHOTREXATE; METHYLPREDNISOLONE; OXYCODONE; SIMVASTATIN;

ACUTE DIARRHEA; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; AUTOPSY; BIRD; BLOOD CULTURE; CASE REPORT; CAT; CAUSE OF DEATH; CHRONIC PAIN; CLINICAL FEATURE; COCCIDIOIDOMYCOSIS; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CORTICOSTEROID THERAPY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DOG; DOMESTIC ANIMAL; DRUG LABELING; ECG ABNORMALITY; ENVIRONMENTAL EXPOSURE; ESCHERICHIA COLI; FEMALE; FEVER; FIBROMYALGIA; HEART CATHETERIZATION; HISTOPLASMOSIS; HORTICULTURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION RISK; INTERVERTEBRAL DISK DEGENERATION; LABORATORY TEST; LEUKOCYTE COUNT; LISTERIA MONOCYTOGENES; LISTERIOSIS; LUNG INFILTRATE; MYOCARDITIS; NAUSEA; OPPORTUNISTIC INFECTION; PHYSICAL EXAMINATION; PLANT; PLEURA EFFUSION; PRIORITY JOURNAL; PROBLEM SOLVING; PSORIASIS; PSORIATIC ARTHRITIS; RESUSCITATION; RHEUMATOID ARTHRITIS; SIDE EFFECT; ST SEGMENT ELEVATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TUBERCULOSIS; URINARY TRACT INFECTION; URINE CULTURE; VOMITING; ALOPECIA; DIARRHEA; FATALITY; HEART ARREST; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; RASH;

ALOPECIA; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; EXANTHEMA; FATAL OUTCOME; FEMALE; HEART ARREST; HUMANS; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MIDDLE AGED; MYOCARDITIS;

EID: 77955300990     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcps0901467     Document Type: Article

References (14)

1. Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. New York: Elsevier/Churchill Livingstone, 2005.
2. Haddad F, Berry G, Doyle RL, Martineau P, Leung TK, Racine N. Active bacterial myocarditis: a case report and review of the literature. J Heart Lung Transplant 2007;26:7459.
3. McCue MJ, Moore EE. Myocarditis with microabscess formation caused by Listeria monocytogenes associated with myocardial infarct. Hum Pathol 1979;10:469-72.
4. Stamm AM, Smith SH, Kirklin JK, McGiffin DC. Listerial myocarditis in cardiac transplantation. Rev Infect Dis 1990;12:820-3.
5. Tice AD, Nelson JS, Visconti EB. Listeria monocytogenes pericarditis and myocardial abscess. R I Med J 1979;62:135-8.
6. Chow LH, Radio SJ, Sears TD, McManus BM. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 1989;14:915-20.
7. Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 1989;64:1235-45.
8. Lyon SA, Berrang ME, Fedorka-Cray PJ, Fletcher DL, Meinersmann RJ. Antimicrobial resistance of Listeria monocytogenes isolated from a poultry further processing plant. Foodborne Pathog Dis 2008;5:253-9.
9. Costa MF, Said NR, Zimmermann B. Drug-induced lupus due to anti-tumor necrosis factor alpha agents. Semin Arthritis Rheum 2008;37:381-7. (Pubitemid 351734520)
10. Wallis RS. Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. Lancet Infect Dis 2008;8:601-11.
11. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 2004;38:12615.
12. Winthrop KL, Yamashita S, Beekmann SE, Polgreen PM. Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network. Clin Infect Dis 2008;46:173840.
13. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295:227585. [Erratum, JAMA 2006;295:2482.]
14. Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2006;54:2368-76. (Pubitemid 44204996)